Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Syndax

Syndax?uq=kzBhZRuG
2005 FOUNDED
PUBLIC STATUS
41-50 EMPLOYEES
SNDX STOCK SYMBOL
$7.23 SHARE PRICE (As of Monday Closing)
Description

Developer of treatments for metastatic breast and lung cancer. The company focuses on an histone deacetylase inhibitor for solid tumors and hematological tumors.

Website
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Stock Exchange
NAS
Primary Office
  • 400 Totten Pond Road
  • Suite 110
  • Waltham, MA 02451
  • United States

+1 (781) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Syndax’s full profile, request a free trial.

Syndax Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$6.33 - $14.82 $164M $7.04 -$3.04 346K 23.4M

Syndax Financials Summary

In Thousands,
USD
TTM
30-Jun-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
FY 2015
31-Dec-2015
Enterprise Value 73,645 83,682 25,116
Revenue 2,256 2,108 1,220 627
EBITDA (73,783) (62,147) (45,339) (22,684)
Net Income (71,976) (60,802) (44,472) (24,119)
Total Assets 105,370 137,186 109,013 89,903
Total Debt 0 0 0 2,981
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Syndax Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Syndax‘s full profile, request access.

Request full access to PitchBook

Syndax Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is reserved for PitchBook Platform users. To explore Syndax‘s full profile, request access.

Request full access to PitchBook
To view this company’s complete Cap Table, request access »

Syndax Executive Team (19)

Name Title Board
Seat
Contact
Info
Briggs Morrison MD Board of Director & Chief Executive Officer
Michael Metzger Chief Operating Officer & President
Richard Shea Chief Financial Officer
Peter Ordentlich Ph.D Chief Technology Officer & Co-Founder
Robert Goodenow Ph.D Chief Business Officer and Secretary

6 Former Executives

You’re viewing 5 of 19 executives. Get the full list »

Syndax Board Members (14)

Name Representing Role Since Contact
Info
Arthur Pappas Pappas Capital Board Member 000 0000
Briggs Morrison MD Syndax Board of Director & Chief Executive Officer 000 0000
George Sledge Jr. Self Director 000 0000
Henry Chen JD Delos Capital (Hong Kong) Board Member 000 0000
Kim Kamdar Ph.D Domain Associates Board Member 000 0000

9 Former Board Members

You’re viewing 5 of 14 board members. Get the full list »